FDA Issues Year’s First Warning Letter for DTC Ad

Drug Industry Daily
A A
The FDA’s Office of Prescription Drug Promotion issued a warning letter to Metuchen Pharma over misleading claims in a print advertisement for its erectile dysfunction drug Stendra (avanafil).

To View This Article:

Login

Subscribe To Drug Industry Daily